Survival in medically treated chronic thromboembolic pulmonary hypertension patients
M. Delcroix (Leuven, Belgium), G. Staehler (Loewenstein, Germany), H. Gall (Giessen, Germany), E. Grünig (Heidelberg, Germany), M. Held (Würzburg, Germany), M. Halank (Dresden, Germany), H. Klose (Dresden, Germany), A. Vonk-Noordegraaf (Amsterdam, Netherlands), S. Rosenkranz (Cologne, Germany), J. Pepke-Zaba (Cambridge, United Kingdom), C. Opitz (Berlin, Germany), S. Gibbs (London, United Kingdom), T. Lange (Regensburg, Germany), I. Tsangaris (Regensburg, Greece), D. Huscher (Regensburg, Germany), D. Pittrow (Dresden, Germany), K. Olsson (Hannover, Germany), M. Hoeper (Hannover, Germany)
Source: International Congress 2018 – Chronic thromboembolic pulmonary hypertension
Session: Chronic thromboembolic pulmonary hypertension
Session type: Oral Presentation
Number: 4943
Disease area: Pulmonary vascular diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Delcroix (Leuven, Belgium), G. Staehler (Loewenstein, Germany), H. Gall (Giessen, Germany), E. Grünig (Heidelberg, Germany), M. Held (Würzburg, Germany), M. Halank (Dresden, Germany), H. Klose (Dresden, Germany), A. Vonk-Noordegraaf (Amsterdam, Netherlands), S. Rosenkranz (Cologne, Germany), J. Pepke-Zaba (Cambridge, United Kingdom), C. Opitz (Berlin, Germany), S. Gibbs (London, United Kingdom), T. Lange (Regensburg, Germany), I. Tsangaris (Regensburg, Greece), D. Huscher (Regensburg, Germany), D. Pittrow (Dresden, Germany), K. Olsson (Hannover, Germany), M. Hoeper (Hannover, Germany). Survival in medically treated chronic thromboembolic pulmonary hypertension patients. 4943
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: